Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize...

Preclinical studies have shown that JSP191 as a single agent safely depletes normal...

discovered 3 months ago on Market Watch
How worms revealed a key protein in insulin synthesis and diabetes

The protein, called TRAP-alpha, is widely shared across worms, flies and mammals, including humans....

discovered 3 months ago on FierceBiotech
Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value

The deal underscores the Paris-based drugmaker’s efforts to build its portfolio of innovative...

discovered 3 months ago on MSN News
New diet that matches biological clock may be better for diabetes

Typically, doctors advise people with type 2 diabetes to eat about six times a day. Could a...

discovered 3 months ago on Medical News Today
Is Metformin Effective For Weight Loss?

A new study found that metformin supports the production of a protein that plays an important role in appetite.

discovered 3 months ago on MSN News
Regenerative Medicine Market Global Industry Trends, Growth, Share, Size and 2026 Forecast Research...

Restraints 3.3. Market Opportunities 4.1. Prevalence and incidence of diabetes, by key countries 4.2. Advancements in insulin delivery devices 4.3. Pricing Analysis, by key ...

discovered 3 months ago on Market Watch
Insulinoma Market to reach USD 3.3 billion by 2023, at CAGR of 3.3 % during the forecast period...

This study was conducted using the families containing diabetes and insulinomas due to the defective gene. TABLE OF CONTENT: Chapter 1. Report Prologue ...

discovered 3 months ago on Market Watch
Viral Inactivation Market : Industry Development Scenario and Forecast to 2025

*Kits and Reagents *Services *Viral Inactivation Systems and Accessories By Application *Blood & Blood Products *Cellular & Gene Therapy Products *Stem Cell Products *Tissue ...

discovered 3 months ago on Market Watch
Gene Therapy Market Current and Upcoming Trends in 2019 - 2024 | Top Key Players are BioVex,...

Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve body's ability to fight disease. < ...

discovered 3 months ago on Market Watch
Sanofi’s CEO Quits Diabetes as Cancer Breakthroughs Beckon

The pharma giant will end its hunt for new diabetes and heart disease drugs, helping save more than...

discovered 3 months ago on Bloomberg via Yahoo Finance
Statins Won't Harm Aging Brains, and May Even Help

Concerns that cholesterol-lowering statin drugs can impair brain health appear to be unfounded, according to new research. "Statins won't make you stupid or cause memory loss," said lead researcher ...

discovered 4 months ago on US News & World Report
Here's Why Dicerna Pharmaceuticals Jumped as Much as 22.1% Today | The Motley Fool

Shares of Dicerna Pharmaceuticals (NASDAQ:DRNA) rose over 22% today after the company announced a...

discovered 4 months ago on The Motley Fool
Comorbidities Can Make Long-QT Syndrome a Package Deal

Some diabetes and various neurologic and psychiatric disorders may share a genetic etiology with...

discovered 4 months ago on Medscape
A Rare Genetic Disorder Turned These Siblings' Blood 'Milky' White

A rare genetic disorder caused three siblings' blood to flood with fat and turn "milky" white,...

discovered 4 months ago on LiveScience
Light-Activated Insulin-Producing Cells May Lead to New Drug-Free Diabetes Treatment

More than 30 million people in the U.S. have diabetes, according to CDC data, but new research from...

discovered 4 months ago on MedicineNet.com
Emerging Therapeutic Strategies for CF-Related Diabetes

Diabetes is a common and important complication of cystic fibrosis, an autosomal recessive genetic disease due to mutations in the cystic fibrosis transmembrane conductance ...

discovered 4 months ago on Medscape
The global cell and gene therapy market is growing at a CAGR of over 24% during the forecast period...

The global cell and gene therapy market is growing at a CAGR of over 24% during the forecast period...

discovered 4 months ago on Olean Times Herald
Gene Therapy Market Latest In-Depth Report Segment by Manufacturers, Type, Applications and Dynamics

Vectors 5.2.2.4. Electroporation 5.2.2.5. Others 5.3. Global Gene Therapy Market, By Application 5.3.1. Infections Disorders 5.3.2... 5.3.4. Oncology Diseases 5.3.5. Cardiovascular ...

discovered 4 months ago on Market Watch
Both old and new drugs may offer fresh ways to fight heart disease

One new study found that heart attack survivors benefited from a medicine long used to treat gout....

discovered 4 months ago on Los Angeles Times
Technology is quickly changing how to treat patients, often kids, with type 1 diabetes

Florida’s medical institutions now offer new and better ways to treat patients with type 1 Diabetes,...

discovered 4 months ago on Miami Herald
Revealed a mechanism of beta-cells involved in the development of type-1 diabetes

L. Pasquali is a Ramon y Cajal researcher at the Josep Carreras Leukaemia Research Institute (IJC),...

discovered 4 months ago on EurekAlert!
10-Q: LEXICON PHARMACEUTICALS, INC.

Compounds from our most advanced drug programs, as well as compounds from a number of additional drug discovery and development programs...from our own internal drug discovery efforts. These ...

discovered 4 months ago on Market Watch
Xconomy: Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate

Danish diabetes giant Novo Nordisk took another step this week in its efforts to establish a...

discovered 4 months ago on Xconomy
Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones

About Genetic Technologies Limited Genetic Technologies Limited (asx:GTG) GENE, -3.35% is a diversified molecular diagnostics company. GTG offers cancer predictive testing ...

discovered 4 months ago on Market Watch
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update

About Zynquista (sotagliflozin) Discovered using Lexicon's unique approach to gene science, Zynquista is an oral dual inhibitor of two proteins responsible for glucose regulation ...

discovered 4 months ago on Market Watch
Orgenesis Third Quarter 2019 Revenue Increases 46% to a Record $9.1 Million

...success of our partnership with Great Point Partners, LLC; our ability to achieve and maintain overall profitability; the sufficiency of working capital to realize our business plans; the development of our transdifferentiation technology as therapeutic treatment for diabetes which could, if...

discovered 4 months ago on Market Watch
Mice Model Market 2019 Revenue analysis Massive Industry Developments, Outlook, Current Trends by...

(Genetically modified sperm-mediated Gene Transfer, Virus/Vector-mediated Gene Transfer, Liposome-mediated DNA & Electroporation of DNA, Biolistics...segmented ...

discovered 4 months ago on Market Watch
Study Shows Blue Light Could Be The Future Of Diabetes Treatment

Diabetes is a condition that affects more than 30 million Americans. In fact, studies have shown...

discovered 4 months ago on MindBodyGreen
Personalized Cell Therapy Market Size and Share worth US$ 53.8 Billion | CAGR of 23.5% by 2027

Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, and Cancer), and by Region (North America, Latin America, Europe...personalized cell therapy market growth ...

discovered 4 months ago on Market Watch
The biggest medical advances of the decade

Over the past 10 years, we've seen major medical advances in the treatment of illnesses like cancer and diabetes.

discovered 4 months ago on MSN News